BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1964358)

  • 1. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
    Rosol TJ; Capen CC; Horst RL
    J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
    Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
    J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
    Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
    Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase activity in fetal rat bone resorbing cells: inhibition by acetazolamide infusion.
    Hott M; Marie PJ
    J Dev Physiol; 1989 Nov; 12(5):277-81. PubMed ID: 2517427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase.
    Hall GE; Kenny AD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):778-82. PubMed ID: 3018220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
    J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.
    Evely RS; Bonomo A; Schneider HG; Moseley JM; Gallagher J; Martin TJ
    J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
    Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
    J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro.
    Beck N; Kim KS; Wolak M; Davis BB
    J Clin Invest; 1975 Jan; 55(1):149-56. PubMed ID: 233968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F; Park M; Goltzman D; Rabbani SA
    Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein stimulates prostaglandin E2 release from human osteoblast-like cells: modulating effect of peptide length.
    Mitnick M; Isales C; Paliwal I; Insogna K
    J Bone Miner Res; 1992 Aug; 7(8):887-96. PubMed ID: 1332431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.